Literature DB >> 26079104

Heroin Use, HIV-Risk, and Criminal Behavior in Baltimore: Findings from Clinical Research.

Robert P Schwartz1, Sharon M Kelly, Jan Gryczynski, Shannon Gwin Mitchell, Kevin E O'Grady, Jerome H Jaffe.   

Abstract

This article reviews research conducted in Baltimore over the past 15 years, examining the following: (1) What factors differentiate heroin-addicted individuals who enter methadone treatment from those who do not? (2) How difficult is gaining access to methadone treatment? (3) What are effective ways to overcome barriers to treatment entry? (4) Why do so many methadone patients drop out of treatment prematurely? (5) What are the added benefits of counseling when coupled with methadone or buprenorphine treatment? (6) Does increasing access to treatment have an impact on overdose deaths? Specific recommendations are made for policymakers concerned with addressing heroin addiction.

Entities:  

Keywords:  Methadone maintenance; buprenorphine treatment; counseling; interim methadone; treatment retention

Mesh:

Substances:

Year:  2015        PMID: 26079104      PMCID: PMC4550504          DOI: 10.1080/10550887.2015.1059222

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  56 in total

1.  Does retention matter? Treatment duration and improvement in drug use.

Authors:  Zhiwei Zhang; Peter D Friedmann; Dean R Gerstein
Journal:  Addiction       Date:  2003-05       Impact factor: 6.526

2.  Facilitating entry into drug treatment among injection drug users referred from a needle exchange program: Results from a community-based behavioral intervention trial.

Authors:  Steffanie A Strathdee; Erin P Ricketts; Steven Huettner; Lee Cornelius; David Bishai; Jennifer R Havens; Peter Beilenson; Charles Rapp; Jacqueline J Lloyd; Carl A Latkin
Journal:  Drug Alcohol Depend       Date:  2005-12-20       Impact factor: 4.492

3.  One-year mortality rates following methadone treatment discharge.

Authors:  D A Zanis; G E Woody
Journal:  Drug Alcohol Depend       Date:  1998-11-01       Impact factor: 4.492

4.  Improving treatment enrollment and re-enrollment rates of syringe exchangers: 12-month outcomes.

Authors:  Michael Kidorf; Van L King; Neeraj Gandotra; Ken Kolodner; Robert K Brooner
Journal:  Drug Alcohol Depend       Date:  2011-12-31       Impact factor: 4.492

Review 5.  Methadone maintenance treatment (MMT): a review of historical and clinical issues.

Authors:  H Joseph; S Stancliff; J Langrod
Journal:  Mt Sinai J Med       Date:  2000 Oct-Nov

6.  A randomized controlled trial of interim methadone maintenance.

Authors:  Robert P Schwartz; David A Highfield; Jerome H Jaffe; Joseph V Brady; Carol B Butler; Charles O Rouse; Jason M Callaman; Kevin E O'Grady; Robert J Battjes
Journal:  Arch Gen Psychiatry       Date:  2006-01

7.  Interim methadone treatment: impact on arrests.

Authors:  Robert P Schwartz; Jerome H Jaffe; Kevin E O'Grady; Timothy W Kinlock; Michael S Gordon; Sharon M Kelly; Monique E Wilson; Ashraf Ahmed
Journal:  Drug Alcohol Depend       Date:  2009-05-14       Impact factor: 4.492

8.  Outcomes of treatment of socially rehabilitated methadone maintenance patients in physicians' offices (medical maintenance): follow-up at three and a half to nine and a fourth years.

Authors:  D M Novick; H Joseph; E A Salsitz; M F Kalin; J B Keefe; E L Miller; B L Richman
Journal:  J Gen Intern Med       Date:  1994-03       Impact factor: 5.128

9.  Exposure to opioid maintenance treatment reduces long-term mortality.

Authors:  Amy Gibson; Louisa Degenhardt; Richard P Mattick; Robert Ali; Jason White; Susannah O'Brien
Journal:  Addiction       Date:  2008-01-08       Impact factor: 6.526

Review 10.  Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.

Authors:  Richard P Mattick; Courtney Breen; Jo Kimber; Marina Davoli
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08
View more
  2 in total

1.  From Long-Term Injecting to Long-Term Non-Injecting Heroin and Cocaine Use: The Persistence of Changed Drug Habits.

Authors:  Don C Des Jarlais; Kamyar Arasteh; Jonathan Feelemyer; Courtney McKnight; David M Barnes; Susan Tross; David C Perlman; Aimee N C Campbell; Hannah L F Cooper; Holly Hagan
Journal:  J Subst Abuse Treat       Date:  2016-08-21

2.  Geographic distribution of risk ("Hotspots") for HIV, HCV, and drug overdose among persons who use drugs in New York City: the importance of local history.

Authors:  D C Des Jarlais; C McKnight; K Arasteh; J Feelemyer; Zev Ross; H L F Cooper
Journal:  Harm Reduct J       Date:  2019-09-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.